NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED)

NCT00256399

CompletedNA

Sponsor: University Hospitals Cleveland Medical Center

Conditions: BPH, Erectile Dysfunction

Interventions: Alfuzosin 10 mg

Countries: United States

Uroxatral (alfuzosin) may not only help BPH symptoms but may also improve sexual function in males with BPH and ED.

Eligibility overview

Sex: MALE

Age: 45 Years to 75 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Males 45-75 years of age
* Confirmed diagnosis of BPH/lower urinary tract symptoms (LUTS) and ED
* Men with steady partner and who agree to attempt sex once a week.

Exclusion Criteria:

* Prostate cancer
* Prostatitis
* Penile disease
* Cardiac co-morbidity
* Pre-existing co-morbid conditions
* History of sensitivity to the drug or similar drugs
* Enrollment in another clinical trial
* Impaired hepatic function
* Impaired renal function
* Mental conditions rendering subject unable to understand the study
* Subjects not likely to comply with protocol

Locations (1)

Cleveland, Ohio, United States